Systemic and regional hemodynamic and biological effects of a new κ-Opioid Agonist, Niravoline, in Healthy Volunteers1

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 232-242

  Bellissant, E ^a   Denolle, T ^b   Sinnassamy, P ^c   Bichet, D G ^d   Giudicelli, J F ^e   Lecoz, F ^b   Gandon, J M ^b   Allain, H ^a  

^a Inst de Rech Contre le Cancer IRCC   (France)

^b Biotrial SA   (France)

^c SANOFI   (France)

^d HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^e BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; KAPPA OPIATE RECEPTOR AGONIST; NIRAVOLINE; NORADRENALIN; PLACEBO; POTASSIUM; RENIN; SODIUM; UNCLASSIFIED DRUG; VASOPRESSIN;

ARTICLE; BLOOD PRESSURE; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIURESIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG INFUSION; ELECTROLYTE BLOOD LEVEL; HEMODYNAMICS; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PHARMACODYNAMICS; PLASMA OSMOLALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINE OSMOLALITY; VASCULAR RESISTANCE; VERTIGO;

ADULT; ATRIAL NATRIURETIC FACTOR; BENZENEACETAMIDES; BLOOD PRESSURE; HEMODYNAMIC PROCESSES; HUMANS; KINETICS; MALE; OSMOLAR CONCENTRATION; PYRROLIDINES; RECEPTORS, OPIOID, KAPPA; RENIN;

EID: 0030433056     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ALDERMAN, E. L., BARRY, W. H., GRAHAM, A. F., AND HARRISON, D. C.: Hemodynamic effects of morphine and pentazocine differ in cardiac patients. N. Engl. J. Med. 287: 623-627, 1972.
2. ASHTON, N., BALMENT, R. J. AND BLACKBURN, T. P.: κ-Opioid-induced changes in renal water and electrolyte management and endocrine secretion. Br. J. Pharmacol. 97: 769-776, 1989.
3. ASHTON, N., BALMENT, R. J. AND BLACKBURN, T. P.: κ-Opioid receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats. Br. J. Pharmacol. 99: 181-185, 1990.
4. BELLISSANT, E., THUILLEZ, C., PUSSARD, E. AND GIUDICELLI, J. F.: Systemic and regional hemodynamic effects of zabicipril in healthy volunteers. Clin. Pharmacol. Ther. 51: 308-319, 1992.
5. BERNSTEIN, D. P.: Noninvasive cardiac output measurement. In Textbook of Critical Care, ed. by W. C. Schoemaker, S. Ayres, A. Grenvik, P. R. Holbrook and W. L. Thompson, 2nd ed., pp. 159-185, W. B. Saunders Co., Philadelphia, 1989.
6. BICHET, D. G., KORTAS, C., METTAUER, B., MANZINI, C., MARC AURÈLE, J., ROULEAU, J. L. AND SCHRIER, R. W.: Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure. Kidney Int. 29: 1188-1196, 1986.
7. BLACKBURN, T. P., BORKOWSKI, K. R., FRIEND, J. AND RANCE, M. J.: On the mechanisms of κ-opioid-induced diuresis. Br. J. Pharmacol. 89: 593-598, 1986.
8. CAUSON, R. C., CARRUTHERS, M. E. AND RODNIGHT, R.: Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal. Biochem. 116: 223-226, 1981.
9. DIXON, W. J., BROWN, M. B., ENGELMAN, L. AND JENNRICH, R. I.: BMDP Statistical Software Manual, University of California Press, Berkeley, CA, 1990.
10. DYKSTRA, L. A., GMEREK, D. E., WINGER, G. AND WOODS, J. H.: κ-Opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects. J. Pharmacol. Exp. Ther. 242: 413-420, 1987a.
11. DYKSTRA, L. A., GMEREK, D. E., WINGER, G. AND WOODS, J. H.: κ-Opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and β-funaltrexamine. J. Pharmacol. Exp. Ther. 242: 421-427, 1987b.
12. FOCACCIO, A., VOLPE, M., AMBROSIO, G., LEMBO, G., PANNAIN, S., RUBATTU, S., ENEA, I., PIGNALOSA, S. AND CHIARIELLO, M.: Angiotensin H directly stimulates release of atrial natriuretic factor in isolated rabbit hearts. Circulation 87: 192-198, 1993.
13. GAVEND, M., GAVEND, M. R. AND SERRE, F.; Etude expérimentale de l'action diurétique d'un antagoniste des morphiniques, la cyclazocine. J. Pharmacol. (Paris) 9: 77-88, 1978.
14. GUTKOWSKA, J., RACZ, K., GARCIA, R., THIBAULT, G., KUCHEL, O., GENEST, J. AND CANTIN, M.: The morphine effect on plasma ANF. Eur. J. Pharmacol. 131: 91-94, 1986.
15. HAMON, G., FORTIN, M., LE MARTRET, O., JOUQUEY, S., VINCENT, J. C. AND BICHET, D. G.: Pharmacological profile of niravoline, a new aquaretic compound. J. Am. Soc. Nephrol. 5: 272, 1994.
16. HOEHE, M. AND DUKA, T.: Opiates increase plasma catecholamines in humans. Psychoneuroendocrinology 18: 141-148, 1993.
17. HUIDOBRO-TORO, J. P. AND PARADA, S.: κ-Opiates and urination: Pharmacological evidence for an endogenous role of the κ-opiate receptor in fluid and electrolyte balance. Eur. J. Pharmacol. 107: 1-10, 1985.
18. LANG, R. E., THÖLKEN, H., GANTEN, D., LUFT, F. C., RUSKOAHO, H. AND UNGER, T.: Atrial natriuretic factor: A circulating hormone stimulated by volume loading. Nature (Lond.) 314: 264-266, 1985.
19. LEANDER, J. D.: A κ-opioid effect: Increased urination in the rat. J. Pharmacol. Exp. Ther. 224: 89-94, 1983a.
20. LEANDER, J. D.: Evidence that nalorphine, butorphanol and oxilorphan are partial agonists at a κ-opioid receptor. Eur. J. Pharmacol. 86: 467-470, 1983b.
21. LEANDER, J. D.: Further study of κ-opioids on increased urination. J. Pharmacol. Exp. Ther. 227: 35-41, 1983c.
22. LEANDER, J. D., HART, J. C. AND ZERBE, R. L.: κ agonist-induced diuresis: Evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels. J. Pharmacol. Exp. Ther. 242: 33-39, 1987.
23. LEANDER, J. D., ZERBE, R. L. AND HART, J. C.: Diuresis and suppression of vasopressin by κ-opioids: Comparison with μ and 6 opioids and clonidine. J. Pharmacol. Exp. Ther. 234: 463-469, 1985.
24. MARTIN, W. R., EADES, C. G., THOMPSON, J. A., HUPPLER, R. E. AND GILBERT, P. E.: The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197: 517-532, 1976.
25. MÉNARD, J., GUYENNE, T. T., CORVOL, P., PAU, B., SIMON, D. AND RONCUCCI, R.: Direct immunometric assay of active renin in human plasma. J. Hypertension 3: suppl. 3, S275-S278, 1985.
26. MILLER, M.: Inhibition of ADH release in the rat by narcotic antagonists. Neuroendocrinology 19: 241-251, 1975.
27. NG, H. W. K., WALLEY, T., TSAO, Y. AND BRECKENRIDGE, A. M.: Comparison and reproducibility of transthoracic bioimpedance and dual beam Doppler ultra-sound measurement of cardiac function in healthy volunteers. Br. J. Clin. Pharmacol. 32: 275-282, 1991.
28. NUTT, J. G. AND JASINSKI, D. R.: Diuretic action of the narcotic antagonist oxilorphan. Clin. Pharmacol. Ther. 15: 361-367, 1974.
29. OHNISHI, A., MIHARA, M., YASUDA, S., TOMONO, Y., HASEGAWA, J. AND TANAKA, T.: Aquaretic effect of the stable dynorphyn-A analog E2078 in the human. J. Pharmacol. Exp. Ther. 270: 342-347, 1994.
30. OISO, Y., IWASAKI, Y., KONDO, K., TAKATSUKI, K. AND TOMITA, A.: Effect of the opioid κ-receptor agonist U-50488H on the secretion of arginine vasopressin. Neuroendocrinology 48: 658-662, 1988.
31. OISO, Y., KONDO, K., ITO, M., IWASAKI, Y. AND OTAKE, K.: Comparison of suppressive effects of opioid κ-, μ- and δ-receptor agonists on arginine vasopressin secretion. Neuroendocrinol. Lett. 12: 443-448, 1990.
32. PETERS, G. R., WARD, N. J., ANTAL, E. G., LAI, P. Y. AND DEMAAR, E. W.: Diuretic actions in man of a selective κ-opioid agonist: U-62,066E. J. Pharmacol. Exp. Ther. 240: 128-131, 1987.
33. PHAM-HUU-TRUNG, M. T. AND CORVOL, P.: A direct determination of plasma aldosterone. Steroids 24: 587-598, 1974.
34. RATHBUN, R. C., KATTAU, R. W. AND LEANDER, J. D.: Effects of μ- and κ-opioid receptor agonists on urinary output in mice. Pharmacol. Biochem. Behav. 19: 863-866, 1983.
35. RICHARDS, M. L. AND SADÉE, W.: In vivo binding of benzomorphans to μ-, δ- and κ-opioid receptors: Comparison with urine output in the rat. J. Pharmacol. Exp. Ther. 233: 425-432, 1985.
36. RIMOY, G. H., BHASKAR, N. K., WRIGHT, D. M. AND RUBIN, P. C.: Mechanism of diuretic action of spiradoline (U-62066E): A κ-opioid receptor agonist in the human. Br. J. Clin. Pharmacol. 32: 611-615, 1991.
37. SAFAR, M. E., PERONNEAU, P. A., LEVENSON, J. A., TOTO-MOUKOUO, J. A. AND SIMON, A. C.: Pulsed Doppler: Diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension. Circulation 63: 393-400, 1981.
38. SINNASSAMY, P., SULTAN, E. AND BICHET, D. G.: Aquaretic effect of niravoline (RU 51599), a κ opioid agonist, in healthy volunteers. J. Am. Soc. Nephrol. 5:373, 1994.
39. SLIZGI, G. R. AND LUDENS, J. H.: Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine. J. Pharmacol. Exp. Ther. 220: 585-591, 1982.
40. 3H-EKC binding by opioids in rat kidney: A correlate to diuretic activity. Life Sci. 36: 2189-2193, 1985.
41. SLIZGI, G. R. AND LUDENS, J. H.: Role of ADH in ethylketocyclazocine-induced diuresis: Studies in the Brattleboro rat. Life Sci. 38: 2437-2440, 1986.
42. SLIZGI, G. R., TAYLOR, C. J. AND LUDENS, J. H.: Effects of the highly selective κ-opioid, U-50,488, on renal function in the anesthetized dog. J. Pharmacol. Exp. Ther. 230: 641-645, 1984.
43. TAKEMORI, A. E., SCHWARTZ, M. M. AND PORTOOHESE, P. S.: Suppression by nor-binaltorphimine of κ-opioid-mediated diuresis in rats. J. Pharmacol. Exp. Ther. 247: 971-974, 1988.
44. TAMMISTO, T., JAATTELA, A., NIKKI, P. AND TAKKI, S.: Effect of pentazocine and pethidine on plasma catecholamine levels. Ann. Clin. Res. 3: 22-29, 1971.
45. TAMMISTO, T., TAKKI, S. AND TOIKKA, P.: A comparison of the circulatory effects in man of the analgesics fentanyl, pentazocine and pethidine. Br. J. Anaesth. 42: 317-324, 1970.
46. THUILLEZ, C., GUERET, M., DUHAZE, P., LHOSTE, F., KIECHEL, J. R. AND GIUDICELLI, J. F.: Nicardipine: Pharmacokinetics and effects on carotid and brachial blood flows in normal volunteers. Br. J. Clin. Pharmacol. 18: 837-847, 1984.
47. VONVOIGTLANDER, P. F., LAHTI, R. A. AND LUDENS, J. H.: U-50,488: A selective and structurally novel non-μ (κ) opioid agonist. J. Pharmacol. Exp. Ther. 224: 7-12, 1983.
48. WELLS, T. AND FORSLING, M. L.: κ-Opioid modulation of vasopressin secretion in conscious rats. J. Endocrinol. 129: 411-416, 1991.
49. YAMADA, K., IMAI, M. AND YOSHIDA, S.: Mechanism of diuretic action of U-62.066E, a κ-opioid receptor agonist. Eur. J. Pharmacol. 160: 229-237, 1989.
50. YAMADA, K., NAKANO, M. AND YOSHIDA, S.: Inhibition of elevated arginine vasopressin secretion in response to osmotic stimulation and acute haemorrhage by U-62066E, a κ-opioid receptor agonist. Br. J. Pharmacol. 99: 384-388, 1990.